Medicare Drug Price Negotiation Program and Medicare Prescription Drug Benefit Program

This proposed rule would codify the Medicare Drug Price Negotiation Program ("Negotiation Program") and would establish certain new policies for the Negotiation Program and the Medicare Prescription Drug Benefit Program as required by the Inflation Reduction Act of 2022. This proposed rule would also propose a modification to the fixed combination drug policy.

This is a factual description of what was issued or decided — not an assessment of it.